tiprankstipranks
Trending News
More News >
Changmao Biochemical Engineering Co. Ltd. Class H (HK:0954)
:0954

Changmao Biochemical Engineering Co. Ltd. Class H (0954) Price & Analysis

Compare
0 Followers

0954 Stock Chart & Stats


Financials

0954 FAQ

What was Changmao Biochemical Engineering Co. Ltd. Class H’s price range in the past 12 months?
Changmao Biochemical Engineering Co. Ltd. Class H lowest stock price was HK$0.26 and its highest was HK$0.61 in the past 12 months.
    What is Changmao Biochemical Engineering Co. Ltd. Class H’s market cap?
    Changmao Biochemical Engineering Co. Ltd. Class H’s market cap is €148.32M.
      When is Changmao Biochemical Engineering Co. Ltd. Class H’s upcoming earnings report date?
      Changmao Biochemical Engineering Co. Ltd. Class H’s upcoming earnings report date is Aug 15, 2025 which is in 71 days.
        How were Changmao Biochemical Engineering Co. Ltd. Class H’s earnings last quarter?
        Changmao Biochemical Engineering Co. Ltd. Class H released its earnings results on Mar 28, 2025. The company reported -HK$0.101 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.101.
          Is Changmao Biochemical Engineering Co. Ltd. Class H overvalued?
          According to Wall Street analysts Changmao Biochemical Engineering Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Changmao Biochemical Engineering Co. Ltd. Class H pay dividends?
            Changmao Biochemical Engineering Co. Ltd. Class H pays a Notavailable dividend of HK$0.086 which represents an annual dividend yield of N/A. See more information on Changmao Biochemical Engineering Co. Ltd. Class H dividends here
              What is Changmao Biochemical Engineering Co. Ltd. Class H’s EPS estimate?
              Changmao Biochemical Engineering Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Changmao Biochemical Engineering Co. Ltd. Class H have?
              Changmao Biochemical Engineering Co. Ltd. Class H has 183,700,000 shares outstanding.
                What happened to Changmao Biochemical Engineering Co. Ltd. Class H’s price movement after its last earnings report?
                Changmao Biochemical Engineering Co. Ltd. Class H reported an EPS of -HK$0.101 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.614%.
                  Which hedge fund is a major shareholder of Changmao Biochemical Engineering Co. Ltd. Class H?
                  Currently, no hedge funds are holding shares in HK:0954

                  Company Description

                  Changmao Biochemical Engineering Co. Ltd. Class H

                  Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, pharmaceutical adjuvant, and active pharmaceutical ingredient, etc. The company is also involved in the research and development of medicine and nutraceutical products; production and sale of food additives; trading of organic acids; and property holding activities. Changmao Biochemical Engineering Company Limited was founded in 1992 and is headquartered in Changzhou, the People's Republic of China.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Bank of Communications Co
                  CSPC Pharmaceutical Group
                  Shanghai Fosun Pharmaceutical (Group) Co
                  Shanghai Pharmaceuticals Holding Co
                  Zijin Mining Group Co
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis